Insider Transactions in Q1 2025 at Cullinan Oncology, Inc. (CGEM)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 25
2025
|
Jacquelyn L Sumer Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,756
-2.67%
|
$30,048
$8.53 P/Share
|
|
Feb 25
2025
|
Jennifer Michaelson Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,756
-2.58%
|
$30,048
$8.53 P/Share
|
|
Feb 25
2025
|
Nadim Ahmed President and CEO |
SELL
Open market or private sale
|
Direct |
12,529
-2.83%
|
$100,232
$8.53 P/Share
|
|
Feb 25
2025
|
Jeffrey Alan Jones Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,895
-2.73%
|
$39,160
$8.53 P/Share
|
|
Feb 19
2025
|
Mary Kay Fenton Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60,000
+50.0%
|
-
|
|
Feb 19
2025
|
Jeffrey Alan Jones Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
65,000
+26.63%
|
-
|
|
Feb 19
2025
|
Nadim Ahmed President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
180,000
+28.89%
|
-
|
|
Feb 19
2025
|
Jacquelyn L Sumer Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+26.23%
|
-
|
|
Feb 19
2025
|
Corrine Savill Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
37,500
+13.47%
|
-
|
|
Feb 19
2025
|
Jennifer Michaelson Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+25.54%
|
-
|
|
Jan 06
2025
|
Jennifer Michaelson Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
4,000
-4.01%
|
$48,000
$12.51 P/Share
|